Glucose News and Research

RSS

Researchers develop artificial inorganic cell-like structures to recreate functions of living cells

Researchers have developed artificial cell-like structures using inorganic matter that autonomously ingest, process, and push out material - recreating an essential function of living cells.

9 Sep 2021

Study finds sharp fall in amputations among people with type 1 diabetes

Amputation in type 1 diabetes is becoming relatively less common in Sweden. The rate has fallen by just over 40 percent over an approximately 20-year period, a University of Gothenburg study shows.

8 Sep 2021

Researchers find potential new target for treating systemic inflammation in obesity

A study led by researchers at the University of Chicago and Indiana University has determined that a protein called elF5A is necessary for driving inflammation in macrophage cells in obesity.

7 Sep 2021

New convection-enhanced MEDs could offer faster, more effective treatment for T1D patients

More than 40 million people worldwide are affected with type 1 diabetes (T1D) mellitus, an autoimmune disease in which insulin producing β-cells in the pancreas are destroyed by the immune system.

6 Sep 2021

Hypopituitarism and COVID-19 – exploring a possible bidirectional relationship?

In a recent study published in Reviews in Endocrine and Metabolic Disorders, the researchers discuss the extra-pulmonary manifestations of COVID-19.

5 Sep 2021

NIH awards $18.15 million to seven projects focused on interoception

The National Institutes of Health is awarding seven projects a total of $18.15 million over five years to a new effort focused on interoception—the ways in which organisms sense and regulate signals within their bodies.

4 Sep 2021

Newly discovered cell type makes survivors of sepsis more vulnerable to infections

Sepsis is the leading cause of death in Brazil's intensive care units (ICUs). Among patients who progress to the severe form of the disease, 40% die, and the survivors often suffer from cardiovascular and neurological complications, as well as a significant decline in immunity lasting for years after they are discharged from hospital.

2 Sep 2021

Review: Remission should be the primary treatment goal of GPs for people with type 2 diabetes

Achieving 'remission' for people with type 2 diabetes through dietary approaches and weight loss should be the primary treatment goal of GPs and healthcare practitioners, concludes a large-scale review of clinical evidence led by researchers at UCL and Aston University.

2 Sep 2021

'Forever chemicals' may increase the risk of type 2 diabetes in Latino girls, study finds

A new USC study finds that a class of environmental pollutants known as "forever chemicals" may increase the risk of type 2 diabetes in Latino girls.

1 Sep 2021

Abdominal fat and weak muscles associated with loss of gait speed in older people

Weak muscles and abdominal fat are a dangerous combination for older people who have difficulty walking.

31 Aug 2021

Researchers explore the fate of dietary fructose in the body

In today's fast-paced world, the dependence on the widely available "fast" foods and beverages has risen. These foods are typically low in fiber and essential nutrients, and often consist of high amounts of added sugar. This shift in dietary trends, accompanied by a sedentary lifestyle, has been attributed to the rise in various metabolic disorders like diabetes, fatty liver disease, and heart disease.

31 Aug 2021

Antisense oligonucleotides engineered to inhibit SARS-CoV-2

In a paper recently uploaded to the bioRxiv* preprint server, structure-based ASOs are developed against SARS-CoV-2, intended to bond with RNA in its structured in situ form, rather than the more rarely encountered linear section, achieving greater affinity and specificity than linear ASOs, and demonstrating inhibition of virus replication in human cells.

30 Aug 2021

$Study identifies drug with a positive effect on heart failure patients with preserved ejection fraction$

Study identifies drug with a positive effect on heart failure patients with preserved ejection fraction

Until now, patients with heart failure with preserved ejection fraction – the most common type of heart failure in the elderly – have had no access to evidenced-based treatments. For the first time, a large clinical trial led by Prof. Dr. Stefan Anker from Charité – Universitätsmedizin Berlin has identified a drug which has a distinctly positive effect on prognosis. In patients affected by this type of heart failure, the drug – empagliflozin – reduces the risk of hospitalization or cardiovascular death by 21 percent. The results of this research have been published in the New England Journal of Medicine.

28 Aug 2021

Pfizer COVID-19 jab side effects likely to be mild to moderate in extremely vulnerable 12-15 year olds

The side effects of the Pfizer-BioNTech jab against COVID-19 are likely to be mild to moderate and clear up quickly in 12-15 year olds at high risk of complications from the infection because of certain coexisting conditions, reveals a small study accepted for publication in the Archives of Disease in Childhood.

28 Aug 2021

$Analysis shows benefits of empagliflozin in heart failure patients with reduced and preserved ejection fraction$

Analysis shows benefits of empagliflozin in heart failure patients with reduced and preserved ejection fraction

A pooled analysis of two randomized trials has demonstrated the beneficial effects of empagliflozin in patients with heart failure with a reduced and preserved ejection fraction. The late breaking study is presented in a Hot Line session today at ESC Congress 2021 and published in the New England Journal of Medicine.

27 Aug 2021

Glucose News and Research

Researchers develop artificial inorganic cell-like structures to recreate functions of living cells

Study finds sharp fall in amputations among people with type 1 diabetes

Researchers find potential new target for treating systemic inflammation in obesity

New convection-enhanced MEDs could offer faster, more effective treatment for T1D patients

Hypopituitarism and COVID-19 – exploring a possible bidirectional relationship?

NIH awards $18.15 million to seven projects focused on interoception

Newly discovered cell type makes survivors of sepsis more vulnerable to infections

Review: Remission should be the primary treatment goal of GPs for people with type 2 diabetes

'Forever chemicals' may increase the risk of type 2 diabetes in Latino girls, study finds

Abdominal fat and weak muscles associated with loss of gait speed in older people

Researchers explore the fate of dietary fructose in the body

Antisense oligonucleotides engineered to inhibit SARS-CoV-2

Study identifies drug with a positive effect on heart failure patients with preserved ejection fraction

Pfizer COVID-19 jab side effects likely to be mild to moderate in extremely vulnerable 12-15 year olds

Analysis shows benefits of empagliflozin in heart failure patients with reduced and preserved ejection fraction

New ESC guidelines for diagnosis and treatment of heart failure published

Study provides important insights into prostate cancer metabolism

Researchers convert human stem cells into beta cells using small molecules

Improving lifestyle and medication use could add healthy years of life after a heart attack

Migraine-inducing peptides may protect against diabetes by influencing insulin production

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News